For interested families who are unable to attend the PPMD Connect Conference there will be an informative Webcast on June 24th from 2:00 PM to 4:30 PM from a panel discussion concerning the drug development process.  This broadcast is hosted by the Parkinson's Action Network. 

NINDS Director Dr. Story Landis is one of several distinguished panelists who will be presenting at the event.  Dr. Landis oversees the Muscular Dystrophy Coordinating Committee (MDCC) which PPMD is a member.

The webcast will be broadcasting a live discussion on the topic of the drug development process.  Go to the Parkinson's Action Network on June 24th to tune in on your home or office computer:  The information is not specific to one disorder, yet will cover many topics related to the development process.

More meeting information follows:

June 24, 2010: You are Invited to the

Emerging Therapies: From Microscope to Marketplace

1:45 p.m. to 4:30 p.m. EDT

Webcast begins at 2 p.m. EDT

A reception will follow the broadcast.


Lohrfink Auditorium in the Rafik B. Hariri Building on the campus of Georgetown University 37th and O Streets, NW Washington, DC 20057


The "Emerging Therapies: From Microscope to Marketplace" interactive Webcast is an educational event about the drug development process. The panel
features members of the scientific community, each involved in a different step
of the drug development pipeline. The panel discussion will feature short
presentations by each speaker followed by questions from the Webcast audience,
the live audience, and the moderator. This discussion will explore the entire
drug development pipeline process, not focus solely on Parkinson's disease,
with a robust discussion about the stages of drug development and how they


Be part of the live audience as the Emerging Therapies interactive Webcast is broadcast online across the country!


Howard Federoff, M.D., Ph.D., Executive Vice President for Health Sciences and Executive Dean of the School of Medicine at Georgetown University will moderate
the panel.


James P. Bennett, Jr., M.D., Ph.D.: Chair, Department of Neurology and Founding Director of the Virginia Commonwealth University Parkinson's Disease and
Movement Disorders Multidisciplinary Research and Clinical Center


Story C. Landis, Ph.D.: Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health


Raymond T. Bartus, Ph.D.: Executive Vice President and Chief Scientific Officer, Ceregene, Inc.


Jackie Hunt Christensen: PAN Minnesota State Coordinator and Clinical Trial Participant


Janet Woodcock, M.D.: Director, Center for Drug Evaluation and Research, Food and Drug Administration

Views: 144

Reply to This

Replies to This Discussion

Thanks Brian. I appreciate this since we can't attend this year.
Hi Cheryl,
I hope you are able to listen to this presentation. I would be interested in knowing what you learn from the discussion and the relevance to DMD.

Reply to Discussion


Need help using this community site? Visit Ning's Help Page.



© 2023   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service